[Video Profile] Sherlock-NMD
When an athlete is injured, their career and value to the team are at risk. At all levels of athletics, including everyday fitness enthusiasts, the […]
Articles by Doug Cress
Cynosure: Profitable, Growing and Flush with Cash, but Investors Don’t Care
Quarterly revenues at Cynosure, a developer of laser-based aesthetic systems, grew 21% year-over-year, from $31.5 million in Q3 2007 to $38.2 million in the most […]
Langer Sheds Orthotics Business to Cut the Fat
Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to […]
Nothing But Sunshine and Roses for Endologix, Save its Share Price
Endologix, developer of a treatment for abdominal aortic aneurysms (AAA), saw revenues increase 42% in its third quarter. The company reported $9.4 million in sales […]
Candela Explores Strategic Alternatives in Challenging Aesthetics Market
First Quarter Results: Revenues at Candela Corporation, a maker of aesthetic lasers, decreased 24 percent year-over-year, to $26.9 million in the most recent quarter from […]
Business as Usual for Endologix as it Considers $98 Million Buyout
More good news from Endologix, the Irvine, CA-based company mulling over a $98 million buyout bid from hedge fund Elliott Associates. This week, the company’s […]
NxStage Medical Signs Long-Term Supply Agreement with Renal Advantage
NxStage Medical has signed a long-term product supply agreement with Renal Advantage (RAI), the fourth largest provider of dialysis services in the U.S. Under the […]
CoreValve Prevails in German Patent Infringement Lawsuit with Edwards
A German Federal Court has found that CoreValve’s ReValving system (for transcatheter aortic valve replacement) does not infringe any of the claims of the Andersen […]
Elliott Associates Submits $98 Million Lowball Bid for Endologix
The New York-based hedge fund, Elliott Associates, has offered to buy all of the outstanding shares of Endologix for $98 million or $2.25 per share. […]
Treating Disc Degeneration from the Inside Out: New Preclinical Data from ISTO Technologies
ISTO Technologies announced positive preclinical data for its spinal disc repair therapy, NuQu. In collaboration with the University of California San Francisco (UCSF), ISTO is […]